Interleukin 18 and its role in autoimmune diseases

Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2003, Vol 20, Issue 2

Abstract

Interleukin 18 (IL-18) was first described in 1989 as interferon γ (IFN-γ) inducing factor. It is a novel cytokine of the IL-1 family. IL-18 is an 18-kDa glycoprotein derived by cleavage of a 23-kDa precursor, pro-IL-18, by caspase 1. Pro-IL-18 is expressed in macrophages, dendritic cells, Kupffer cells, keratinocytes, chondrocytes, synovial fibroblasts and osteoblasts, while IL-18 receptor is present on naive T-lymphocytes, mature T-helper cells-type 1 (Th1) cells, natural killer cells (NK), macrophages, neutrophils and chondrocytes. IL-18 acts via its receptor and signals through the IL-1 pathway which involves myeloid differentiation primary response protein, IL-1-receptor associated kinase, tumor necrosis factor α receptor-associated factor 6, transforming growth factor β activated kinase 1 and its binding protein, and activation of nuclear factor kB. IL-18 participates in both innate and acquired immunity. It induces Th1 maturation and activation of lymphocytes. IL-18 activates macrophages and induces cytokine release and nitric oxide production and it can enhance cell-to-cell interactions. It reduces chondrocyte proliferation, up-regulates nitric oxide synthase, stromelysin and cyclooxygenase 2 expression and enhances glycosaminoglycan release. In addition, IL-18 induces cytokine release and cytotoxicity from NK-cells and promotes angiogenesis from endothelial cells. Furthermore, it activates neutrophils while inhibiting osteoclast maturation. Regulation of IL-18 is mediated via IL-18 binding protein, a specific inhibitor for IL-18, which binds IL-18 with high affinity and neutralizes its function. It seems that IL-18 has a role in various rheumatic diseases. IL-18 mRNA and protein have been detected in rheumatoid arthritis (RA) synovial tissues while IL-18 receptor was also detected on synovial lymphocytes and macrophages. IL-18 seems to have a proinflammatory role in RA. It potentiates IL-12-induced IFN-γ production by T-cells in RA synovium. Overproduction

Authors and Affiliations

P. VOULGARI, A. DROSOS

Keywords

Related Articles

Data analysis: Non Bayesian approach

An epidemiologic study can be viewed as an exercise in measurement. As in any measurement, the goal is to obtain an accurate result, with as little error as possible. There are three types of error; random error, systema...

The association between socio-economic status and mental disorders

Poverty and related conditions such as unemployment and low educational status are associated with a higher prevalence of mental and behavioural disorders. This higher prevalence may be due to the observation that poor p...

Antiviral drugs for the treatment of HIV-seropositive patients:<br /> nephrotoxicity and dose adjustments in renal insufficiency

Patients with HIV infection and HIV-related opportunistic infections and malignancies are treated extensively with a broad spectrum of drugs. The introduction of new antiretroviral drugs, such as protease inhibitors and...

Current treatment of descending thoracic aortic aneurysms

Vascular diseases occur very often in Greece, as in all countries of the western world, and their incidence is expected to increase as life expectancy increases. The incidence of thoracic aortic aneurysms is calculated a...

Download PDF file
  • EP ID EP144452
  • DOI -
  • Views 84
  • Downloads 0

How To Cite

P. VOULGARI, A. DROSOS (2003). Interleukin 18 and its role in autoimmune diseases . Αρχεία Ελληνικής Ιατρικής, 20(2), 172-181. https://europub.co.uk/articles/-A-144452